论文信息 - Interferon-α2b as Therapy for Untreated and Pretreated Patients with Ph1 Positive Chronic Myelogenous Leukemia - 字舞流文

Interferon-α2b as Therapy for Untreated and Pretreated Patients with Ph1 Positive Chronic Myelogenous Leukemia

F. Mandelli | F. Dianzani | F. Grignani | E. Morra | M. Lazzarino | M. Mancini | G. Alimena | A. Liberati | E. Donti | P. Bernasconi | C. Bernasconi | E. Montefusco | D. Inverardi

[1] F. Grignani,et al. Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administration. , 1988, Blood.

[2] H. Kantarjian,et al. Clinical investigation of human alpha interferon in chronic myelogenous leukemia. , 1987, Blood.

[3] E. Morra,et al. Hydroxyurea and 6‐Mercaptopurine in the Treatment of Chronic Granulocytic Leukemia , 1986, American Journal of Clinical Oncology.

[4] D. Golde,et al. Chronic myelogenous leukemia: recent advances. , 1985, Blood.

[5] B. Barlogie,et al. Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6] Francisco Cervantes,et al. Prognostic discrimination in "good-risk" chronic granulocytic leukemia , 1984 .

[7] J. Gutterman,et al. Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia. , 1983, Blood.